Red Sun Pharmaceutical: Chase Group intends to passively reduce its stake of no more than 2.13%

[red Sun Pharmaceutical: chase Group intends to passively reduce its stake of no more than 2.13%] Red Sun Pharmaceutical announced that due to contract disputes, 64.0795 million shares of the company held by Chase Group (accounting for 2.13% of the company's total share capital) were ruled by the Tianjin third Intermediate Court to sell through block trading and collective bidding to repay debts on the premise of complying with the relevant shareholding reduction regulations.